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Abstract Neuromodulatory systems originate in nuclei
localized in the subcortical region of the brain and control
fundamental behaviors by interacting with many areas of
the central nervous system. An exploratory survey of the
cholinergic, dopaminergic, noradrenergic, and serotonergic
receptor expression energy in the amygdala, and in the
neuromodulatory areas themselves was undertaken using
the Allen Mouse Brain Atlas. The amygdala was chosen
because of its importance in cognitive behavior and its
bidirectional interaction with the neuromodulatory sys-
tems. The gene expression data of 38 neuromodulatory
receptor subtypes were examined across 13 brain regions.
The substantia innominata of the basal forebrain and
regions of the amygdala had the highest amount of receptor
expression energy for all four neuromodulatory systems
examined. The ventral tegmental area also displayed high
receptor expression of all four neuromodulators. In con-
trast, the locus coeruleus displayed low receptor expression
energy overall. In general, cholinergic receptor expression
was an order of magnitude greater than other neuromodu-
latory receptors. Since the nuclei of these neuromodulatory
systems are thought to be the source of specific neuro-
transmitters, the projections from these nuclei to target
regions may be inferred by receptor expression energy. The
comprehensive analysis revealed many connectivity rela-
tions and receptor localization that had not been previously
reported. The methodology presented here may be applied
to other neural systems with similar characteristics, and to
other animal models as these brain atlases become
available.
Keywords Neuromodulatory systems  Neuroinformatics 
mRNA in situ hybridization  Allen Mouse Brain Atlas 
Amygdala  Gene expression
Introduction
Neuromodulatory systems, composed of relatively small
nuclei of neurons, are located in the sub-cortical region of
the brain and control fundamental behaviors through
interactions with broad areas of the nervous system (Briand
et al. 2007; Krichmar 2008). These systems have distinct
neurotransmitters, which include norepinephrine, dopa-
mine, serotonin, and acetylcholine, and distinct sources of
those neurotransmitters. When a biological organism
experiences an important event in the environment, the
activation of the neuromodulatory system contributes to the
organism’s ability to commit an action accordingly. These
actions include mitigating responses to risks, rewards,
attentional effort, and novelty. Thus, it is important to
understand the underlying structure of these neuromodu-
latory systems as it plays a role in higher-order cognition
and in an organism’s survival.
The nuclei of many neuromodulatory systems have
neurons that are the origins of a specific neurotransmitter.
Cholinergic neurons, which originate in the basal forebrain,
project to the cortex, amygdala, and hippocampus. Basal
forebrain cholinergic neurons appear to modulate attention
and optimize information processing (Baxter and Chiba
1999). Cholinergic neurons also originate in the brainstem
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pedunculopontine and laterodorsal tegmental nuclei and
have projections to the amygdala, basal forebrain, and
the ventral tegmental area (Semba and Fibiger 1992;
Holmstrand and Sesack 2011). Dopamine (DA) is produced
by two groups of cell bodies in the mesencephalon: the
substantia nigra (SN) and the ventral tegmental area
(VTA). The VTA projects to the nucleus accumbens (NAc)
and is the pathway implicated in mediating reward related
behaviors (Hyman et al. 2006). The SN is the source of
dopamine in the basal ganglia. Both the SN and VTA
project to the hippocampus (Scatton et al. 1980). Norepi-
nephrine (NE) in the central nervous system is produced by
the locus coeruleus, which projects to virtually all brain
regions with the exception of basal ganglia (Berridge and
Waterhouse 2003). The nucleus of the solitary tract (NTS)
is another source of norepinephrine. There is a feedback
loop in which the amygdala affects stress hormones, and
then the stress hormones acts on the NTS, which then acts
on the locus coeruleus, resulting in the release of NE in the
amygdala. Norepinephrine activation in the amygdala helps
to consolidate and modulate memory in other brain regions
(McGaugh 2004). Serotonergic projections, which origi-
nate in the raphe nuclei of the brainstem, extend to almost
all forebrain areas (Barnes and Sharp 1999; Hornung
2003). The cortex, ventral striatum, hippocampus, and
amygdala are amongst the areas that are innervated by
raphe efferents (Harvey 2003; Meneses and Perez-Garcia
2007). Because the sources of these neuromodulatory
transmitters are well established, we may be able to infer
their connectivity to other brain regions by examining the
specific neurotransmitter receptor expression.
In recent years, analyzing gene expression data has
become an effective means of investigating the structural
organization, distribution and connectivity of the nervous
system. Expression of genes is a process elucidated by the
production of ribonucleic acid (RNA) transcripts within
cells. In situ hybridization localizes these transcripts at cel-
lular resolution, and allows researchers to determine whether
a given gene is expressed in specific cells (Jin and Lloyd
1997). Using this technique, many elements important to
neuronal processing, such as receptors, transporters, growth
factors, etc., can be localized by detecting specific messenger
ribonucleic acid (mRNA) sequences. There are several
publicly accessible large-scale databases that explore
mRNA and protein localization in the mammalian central
nervous system to give other members of the scientific
community access to use their datasets (Bota et al. 2003;
Visel et al. 2004; Christiansen et al. 2006). Gene Expression
Nervous System Atlas (GENSAT) is one such database that
provides a collection of gene expression maps of the mouse
brain and spinal cord (http://www.gensat.org) (Heintz 2004).
GENSAT uses in situ hybridization as a screening process to
visualize selected genes through enhanced green fluorescent
protein (EGFP) expression on bacterial artificial chromo-
some (BAC) transgenic mice to generate an atlas of gene
expression in the mouse brain (Heintz 2004).
In addition, there exist databases that provide insight on
brain circuitry through use of existing data originating from
pathway tracing and imaging techniques, such as the Brain
Architecture Management System (BAMS) and the Col-
lation of Connectivity on the Macaque Brain (CoCoMac).
BAMS is an online knowledge management system that
stores and infers relationships between data about the
structural organization of mammalian central nervous
system circuitry (http://brancusi.usc.edu/bkms/) (Bota et al.
2005). CoCoMac provides large-scale wiring diagram of
the primate cerebral cortex for use in brain system analysis
and computational modeling (http://cocomac.org/) (Ko¨tter
2004). However, it is not always possible with these dat-
abases to specify the neurotransmitter associated with a
projection. Moreover, these databases are not necessarily
complete and may not contain experiments on connectivity
between certain brain regions.
In this survey, we used a resource from the Allen
Institute for Brain Science called the Allen Mouse Brain
Atlas (ABA), a project that features an interactive, com-
prehensive, genome-wide image database of expression
data for over 20,000 genes (Lein et al. 2007; Sunkin and
Hohmann 2007; Ng et al. 2007). A combination of RNA
in situ hybridization data, detailed Reference Atlases, and
informatics analysis tools are integrated to provide a
searchable digital atlas of gene expression (Lein et al.
2007). For each gene that has a successful probe, quantified
expression energy can be extracted and analyzed.
Researchers have utilized the ABA in a variety of pro-
jects, from validating gene expression patterns seen in other
species through various methodologies to encouraging new
scientific discoveries in gene association, brain organiza-
tion, behavior, and disease (Jones et al. 2009). For instance,
French and Pavlidis (2011) used the ABA, along with
BAMS, to show that gene expression signatures have a
statistical relationship to connectivity (French and Pavlidis
2011). Other researchers have applied statistical compo-
nent analysis techniques to gene expression data from the
ABA to understand the genetic neuroanatomical architec-
ture of the hippocampus (Thompson et al. 2008). One ABA
study reviewed the expression of uridine diphosphate
(UDP)-glucuronosyltransferase (UGT) and how it is dis-
tributed across neural areas involved with olfaction (Heydel
et al. 2010). Despite the ABA having a wide application
within neuroscience, there still remains a vast array of
uncharted genomic data analysis (Jones et al. 2009).
The present study investigates the receptor expression
energy among some of the classic neuromodulatory
systems, and their interaction with the amygdala. The
amygdala was chosen due to its importance in learning and
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memory, and because it is known to be strongly innervated
by neuromodulators (Gallagher and Chiba 1996; McGaugh
2004, 2006). Since the neuromodulatory systems have
localized sources and specific neurotransmitters, we sug-
gest that connectivity relationships can be inferred by
examining the expression energy of receptors specific to
those neuromodulatory systems. For example, the expres-
sion energy of adrenergic receptors in the ventral tegmental
area may imply that either the nucleus of the solitary tract
or locus coeruleus has a direct projection to this dopami-
nergic system. Based on this assumption, an exploratory
survey of the noradrenergic, cholinergic, dopaminergic,
and serotonergic receptor expression energy in the amyg-
dala and within anatomical origins of neuromodulatory
systems was undertaken using the ABA. The comprehen-
siveness of the mouse ABA allowed us to better analyze
and understand the organization of brain circuitry involved
with classic neuromodulators. Using this methodology, the
present study makes predictions regarding neuromodulator
connectivity and receptor localization.
Methods
The ABA is a standardized atlas of gene expression data
from 56-day-old male C57BL/6J mice strains visualized by
in situ hybridization (ISH) using a non-radioactive,
digoxigenin-labeled anti-sense riboprobes. ABA provides
an Application Programming Interface (API) to access
gene expression energy in different anatomical regions
of the mouse brain atlas (http://community.brain-map.org/
confluence/display/DataAPI/Home). The API features a
number of method calls that allow users to obtain data
including high-resolution images, expression data from an
experiment’s image series and 3D coordinates for atlas-
annotated structures in 200-lm resolution.
To investigate expression energy volumes in the brain
regions of interest, we wrote a Java program to access the
ABA via calls to its API methods (data retrieved 28
February 2012). In particular, two ABA API methods were
utilized for the survey: Gene API and Expression Energy
Volumes API. The Gene API method was first used to
obtain a listing of image series identification (ID) numbers
given a list of genes (Table 1). The Expression Energy
Volumes API returned gene expression energy data per
voxel of the mouse brain for a given ID. The volume space
returned by this method was divided into individual
200 lm 3D cubic sagittally arranged voxels on an
(x, y, z) coordinate plane. Expression energy value, as
defined in the ABA, represents the density of expression
within a 200 lm voxel from grid data taken per image
series ID (sum of expressing pixels/sum of all pixels in
division) divided by the pixel intensity of expression in that
voxel (sum of expressing pixel intensity/sum of expressing
pixels). To account for different sized brain regions,
expression energy values for a brain region were normal-
ized by dividing the number of voxels in a brain region that
contained expression energy by the maximum number of
voxels for that given brain area. We made no attempt to
normalize based on neuron size, but rather looked at
receptor gene expression per anatomical region.
The (x, y, z) coordinates associated with an expression
energy were mapped to brain structures using the annotated
atlas provided with the ABA API main site (AtlasAnno-
tation200.sva). The annotated atlas provided an identifier
for a brain structure at a given coordinate. This identifier
was then compared with a separate dataset file (brain-
structures.csv) to obtain the name of the brain region
associated with the identifier. For instance, suppose an
expression energy value was found at coordinate
(40, 26, 26) for the dopamine receptor, Drd1a. The Atlas-
Annotation200.sva would reveal that those coordinates
corresponded to the informatics ID number 139, which the
brainstructures.csv file would then indicate that the infor-
matics ID represented the VTA of the mouse brain.
Brain regions
Expression data from the ABA were extracted from 13
different brain regions (Fig. 1). Ten of those regions are
considered to be sources of neuromodulatory systems:
noradrenergic (locus coeruleus, LC; nucleus of the solitary
tract, NTS), cholinergic (substantia innominata, SI; mag-
nocellular nucleus, MA; pedunculopontine nucleus, PPN),
dopaminergic (ventral tegmental area, VTA), and seroto-
nergic (dorsal raphe nucleus, DR; superior central nucleus
raphe, CS; central linear nucleus raphe, CLI; nucleus raphe
pontis, RPO) (Bhatia et al. 1997; Mesulam et al. 1983;
Sodhi and Sanders-Bush 2004; Hornung 2003). The
remaining three brain regions are in the amygdala (i.e.,
anterior amygdalar area, AAA; central amygdalar nucleus,
CEA; medial amygdalar nucleus, MEA), which were
chosen in this survey because of their strong bidirectional
interaction with neuromodulatory systems (Bouret et al.
2003; Han et al. 1999; Lee et al. 2011; McGaugh 2004;
Woolf and Butcher 1982). Note that the dopaminergic
substantia nigra pars compacta was not included because it
is thought to project primarily to the basal ganglia, an area
not included in this study.
Neuromodulatory genes
We performed a search in the ABA, using the Gene API,
for all known neuromodulatory receptor genes, which
included 5 dopaminergic, 16 serotonergic, 19 cholinergic,
and 9 adrenergic receptors for a total of 49 different
Brain Struct Funct (2013) 218:1513–1530 1515
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receptor types (Dani and Bertrand 2007; Hoyer et al. 2002;
Ishii and Kurachi 2006; Lan et al. 2006; Nicholas et al.
1996). Of these 49, only 38 receptors were available for
evaluation (Table 1). For example, some receptor genes,
such as Drd4 and Drd5, were not available in the ABA, and
thus, were not included in the present study. Although
ABA data may extend from mouse brain tissue, all genes
listed in Table 1 are orthologous to rat and human genes
according to the Mouse Genome Informatics database
(http://www.informatics.jax.org).
While the detection sensitivity for different probes may
vary across mRNA species, the ABA has performed vali-
dation experiments to ensure consistent data quality and
internal reproducibility (Lein et al. 2007; Lee et al. 2008).
In every ISH run, a positive control slide was incubated
with a Drd1a riboprobe and a negative control was
Table 1 List of neuromodulatory genes accessed from the ABA
Gene symbol Gene name ImageSeriesID Receptor subtype
Adra1a Adrenergic receptor, alpha 1a 74277700 Gq-protein coupled
Adra1d Adrenergic receptor, alpha 1d 69236807 Gq-protein coupled
Adra2a Adrenergic receptor, alpha 2a 70723343 Gi-protein coupled
Adra2c Adrenergic receptor, alpha 2c 70723357 Gi-protein coupled
Adrb1 Adrenergic receptor, beta 1 77340494 Gs/Gi-protein coupled
Adrb2 Adrenergic receptor, beta 2 68744522 Gs/Gi-protein coupled
Chrm1 Cholinergic receptor, muscarinic 1 73907497 Gq/Gs/Gi-protein coupled
Chrm2 Cholinergic receptor, muscarinic 2 70560343 Gi-protein coupled
Chrm3 Cholinergic receptor, muscarinic 3 2095 Gq-protein coupled
Chrm4 Cholinergic receptor, muscarinic 4 261 Gi-protein coupled
Chrm5 Cholinergic receptor, muscarinic 5 74821591 Gq-protein coupled
Chrna1 Cholinergic receptor, nicotinic, alpha polypeptide 1 75551465 Ligand-gated Na?/K? cation channel
Chrna2 Cholinergic receptor, nicotinic, alpha polypeptide 2 75551460 Ligand-gated Na?/K? cation channel
Chrna3 Cholinergic receptor, nicotinic, alpha polypeptide 3 69734723 Ligand-gated Na?/K? cation channel
Chrna4 Cholinergic receptor, nicotinic, alpha polypeptide 4 1173 Ligand-gated Na?/K? cation channel
Chrna5 Cholinergic receptor, nicotinic, alpha polypeptide 5 74821601 Ligand-gated Na?/K? cation channel
Chrna6 Cholinergic receptor, nicotinic, alpha polypeptide 6 75551461 Ligand-gated Na?/K? cation channel
Chrna7 Cholinergic receptor, nicotinic, alpha polypeptide 7 69237107 Ligand-gated Na?/K?/Ca2? cation channel
Chrna9 Cholinergic receptor, nicotinic, alpha polypeptide 9 74821602 Ligand-gated Na?/K? cation channel
Chrnb1 Cholinergic receptor, nicotinic, beta polypeptide 1 75831174 Ligand-gated Na?/K? cation channel
Chrnb2 Cholinergic receptor, nicotinic, beta polypeptide 2 2097 Ligand-gated Na?/K? cation channel
Chrnb3 Cholinergic receptor, nicotinic, beta polypeptide 3 79760470 Ligand-gated Na?/K? cation channel
Drd1a Dopamine receptor D1A 352 Gs-protein coupled
Drd2 Dopamine receptor 2 357 Gi/Go-protein coupled
Drd3 Dopamine receptor 3 69859867 Gi/Go/Gs-protein coupled
Htr1a 5-Hydroxytryptamine receptor 1A 79394355 Gi/Go-protein coupled
Htr1b 5-Hydroxytryptamine receptor 1B 583 Gi/Go-protein coupled
Htr1d 5-Hydroxytryptamine receptor 1D 71393418 Gi/Go-protein coupled
Htr1f 5-Hydroxytryptamine receptor 1F 69859867 Gi/Go-protein coupled
Htr2b 5-Hydroxytryptamine receptor 2B 71664130 Gq/G11-protein coupled
Htr2c 5-Hydroxytryptamine receptor 2C 71393424 Gq/G11-protein coupled
Htr3a 5-Hydroxytryptamine receptor 3A 74724760 Ligand-gated Na?/K? cation channel
Htr3b 5-Hydroxytryptamine receptor 3B 68745408 Ligand-gated Na?/K? cation channel
Htr4 5-Hydroxytryptamine receptor 4 69257849 Gs-protein coupled
Htr5a 5-Hydroxytryptamine receptor 5A 71393430 Gi/Go-protein coupled
Htr5b 5-Hydroxytryptamine receptor 5B 69257975 Gi/Go-protein coupled
Htr6 5-Hydroxytryptamine receptor 6 69257981 Gs-protein coupled
Htr7 5-Hydroxytryptamine receptor 7 71393436 Gs-protein coupled
ImageSeriesID is an identification number for the experiment used to analyze gene expression
1516 Brain Struct Funct (2013) 218:1513–1530
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incubated in hybridization buffer without that riboprobe
(Lein et al. 2007). These slides were then used to determine
whether data from the run would advance into their data
analysis pipeline by qualitatively scoring the run as ‘Pass’
or ‘Fail’. In addition, an experiment was performed to
replicate data across a series of days, using riboprobes
generated in parallel through in vitro translation, which
include Calb1, Calb2, Cst3, Dkk3, Gad1, Man1a, Plp1,
Pvalb, and Nov (Lee et al. 2008). For each gene, an
independently synthesized probe was hybridized on con-
secutive serial sections from the same brains over the span
of 4 days, which maximizes comparability over time while
minimizing other biological variability, including differ-
ential hapten incorporation in riboprobes, and batch reagent
preparation variability. The results reported in Lee et al.
(2008) demonstrate consistency of the ABA ISH platform.
In cases when multiple experiments (image series IDs)
for a particular gene were found, we compared existing
gene expression with the same search string and used the
experiment that contained the highest expression energy
data within brain regions of interest.
GABA and glutamate genes
We also surveyed, exclusively within the SI and LC, the
expression energy of GABA and glutamate receptors. We
followed the same procedures as before when looking at
neuromodulatory receptors. However, we instead searched
and found all known GABA and glutamate receptors in the
ABA via Gene API, which includes 17 GABAA, 2
GABAB, 4 AMPA, 5 kainate, 7 NMDA, and 7 mGluR
receptors for a total of 42 different receptors. All GABA
and glutamate genes are orthologous to rat and human
genes according to the Mouse Genome Informatics data-
base (http://www.informatics.jax.org).
Results
Using the ABA, we conducted a comprehensive analysis of
available neuromodulator receptor gene expression (see
Table 1) in areas regarded as sources of neuromodulation,
as well as the amygdala (see Fig. 1). The expression energy
Fig. 1 Image of reference atlas highlighting brain regions examined
in the survey of neuromodulatory genes using the Allen Mouse Brain
Atlas dataset. Brain regions studied include: dorsal raphe nucleus
(DR), superior central nucleus raphe (CS), central linear nucleus
raphe (CLI), nucleus raphe pontis (RPO), ventral tegmental area
(VTA), locus coeruleus (LC), nucleus of the solitary tract (NTS),
substantia innominata (SI), magnocellular nucleus (MA), pedunculo-
pontine nucleus (PPN), anterior amygdalar area (AAA), central
amygdalar nucleus (CEA) and medial amygdala nucleus (MEA).
Image originally from the Allen Mouse Brain Reference Atlas
(http://mouse.brain-map.org/static/atlas)
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for all receptor subtypes, in which data was available in the
ABA, was examined in all the brain regions of interest.
Total expression and individual receptor subtypes
In the examined brain regions, expression energy of cho-
linergic receptors was much higher and expression energy
of adrenergic receptors was much lower than that for
dopaminergic and serotonergic receptors. Figure 2 shows
the total expression energy for available adrenergic, cho-
linergic, dopaminergic, and serotonergic receptors from the
ABA across the 13 brain regions examined (note the dif-
ferent scale on the x-axes of Fig. 2). Each bar in Fig. 2
represents gene expression energy when combining all
receptor subtypes per region. Brain regions were ranked
and arranged based on total expression in Fig. 2, with the
brain region having the highest expression energy at the top
bar of each plot.
The SI of the basal forebrain, amygdala (AAA, CEA,
and MEA), and the VTA had relatively high levels of
receptor expression energy. The SI had the highest receptor
expression energy of all neuromodulatory regions tested,
implying that this region of the basal forebrain is strongly
innervated by all neuromodulatory systems (see Fig. 2).
The amygdala closely followed SI in terms of overall
neuromodulatory receptor expression energy, but expression
energy in the amygdala differed based on neuromodulatory
receptor type and amygdala subregions. For example, MEA
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Fig. 2 Total expression energy
per brain region when
combining all subtypes. Gene
expression values for each
subtype were collapsed into
their respective
neuromodulatory systems and
separated by brain region. Brain
regions were arranged from
most (top) to least (bottom)
amount of total expression
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had the highest adrenergic, cholinergic, and serotonergic
receptor expression energy among the amygdala regions.
However, the CEA had the most dopaminergic receptor
expression energy. Similar to the SI, the VTA, which
contains dopaminergic neurons, displayed high expression
energy for all neuromodulatory receptors.
Somewhat surprisingly, the LC and raphe nuclei (DR,
CS, CLI, and RPO), which are sources of norepinephrine
and serotonin, respectively, did not have high expression
energy of neuromodulatory receptors relative to the other
regions examined (see Fig. 2). Because the expression
energy was normalized by area, this difference should not
be due to the smaller size of these brain regions.
Different brain areas had distinct patterns of receptor
subtype expression. Expression energy for individual recep-
tor subtypes across all neuromodulatory systems are shown in
Fig. 3. Subtypes were sorted by expression per neuromodu-
latory system with the top charts having the highest expres-
sion. Within each neuromodulatory system, the arrangement
of brain regions from left to right on each chart was based on
their overall expression as in Fig. 2. It is apparent that the
distribution of gene expression per subtype from one brain
region to another was not uniform (Fig. 3). However, looking
at individual expression energy helps identify receptor sub-
types that contribute to the total expression of a particular
brain region being described in Fig. 2.
The expression profile of SI, for example, which has the
highest receptor expression energy among all for neuromod-
ulatory regions (Fig. 2), may be influenced by select subtypes
within neuromodulatory systems. For instance, within the
adrenergic receptors, Adra1d and Adrb2 made up for a large
portion of the expression energy found in SI, while the
remaining four adrenergic receptors did not contribute nearly
as much (Fig. 3a). The cholinergic system, which had the most
receptor subtypes, was dominated by the expression of the
muscarinic subtypes Chrm1, Chrm2 and Chrm4, and the
nicotinic Chrna1 (Fig. 3b). Even the dopaminergic system,
having the fewest receptor subtypes, had differing receptor
expression, with Drd1a and Drd2 having much higher
expression value in SI than Drd3 (Fig. 3c). Lastly, serotonergic
receptors Htr2c, Htr1f, Htr1a, and Htr1b described most of the
total expression energy in SI with comparatively lower con-
tribution from the other subtypes (Fig. 3d).
Among the neuromodulatory sources, VTA also displayed
higher overall receptor expression energy compared to other
regions. In general, many of the subtypes that have noticeably
high expression energy in the SI also have high energy in the
VTA (Fig. 3). The main difference we observed was the
muscarinic receptor (Chrm2), the nicotinic (Chrna4, Chrna6,
Chrnb3), and the dopaminergic Drd2 receptor expression was
higher in VTA than in SI (compare Fig. 3b with c).
Different regions of the amygdala have distinct pat-
terns of neuromodulatory receptor expression energy.
The neuromodulatory receptor expression energy found in
the amygdala, which was among the highest of the brain
regions studied in this survey, differed based on the neu-
romodulatory system (Fig. 2), amygdalar subregion, and by
receptor subtypes (Fig. 3). For ease of visualization, pie
charts were used to illustrate how receptor subtypes were
distributed within the different amygdala areas (Fig. 4).
Figure 4 revealed a similar distribution set of prominent
gene expression across the amygdala areas with similar
proportions. In the adrenergic system, Adra1a was highly
expressed in the CEA and AAA, but lower in the MEA. In
contrast, Adrb2 had higher expression energy in MEA than
in AAA or CAE (Fig. 4, first row). The nicotinic receptor
Chrna1 and the muscarinic receptor Chrm1 were more
highly expressed across all the amygdala areas in com-
parison to other nicotinic and muscarinic receptors, though
it is interesting to note that Chrm2 had relatively higher
expression in the AAA as compared to CEA and MEA
(Fig. 4, second row). Dopamine and serotonin receptors
also showed differences in receptor expression energy
across the amygdala. Drd2 and Htr1f contributed most
strongly to the expression found in the CEA, whereas
Drd1a and Htr2c contributed most strongly to the expres-
sion found in the AAA and MEA regions (Fig. 4, third and
fourth row).
Hierarchical clustering analysis
To illustrate the relationship between neuromodulatory
receptor expression energy and brain region, hierarchical
cluster analyses were performed for expression energy and
anatomical location. A hierarchical clustering analysis is a
commonly used exploratory technique to handle a large set of
data whose interrelationships are elusive and not fully
understood. The cluster analysis assigned subsets of gene
expression data into groups based on the similarity in their
expression patterns (Fig. 5a), and based on the location of the
brain regions examined (Fig. 5b). A hierarchy of groupings
can emerge using this methodology, and such analyses have
previously shown relationships between biological function
and anatomical location (Gerstein and Jansen 2000).
To perform the receptor expression energy cluster
analysis, a vector of the total expression across the 38
genes was constructed for each of the 13 brain regions. The
pairwise distance between these vectors were calculated
using Euclidean distance. To create the dendrogram in
Fig. 5a, an Unweighted Pair Group Method with Arith-
metic Mean (UPGMA) was calculated based on the
Euclidean distance metric. Threshold values in Fig. 5a
represented the computed distance and linkage between
brain regions. The cutoff for determining clusters was set to
a threshold of 0.19 to yield three separate clusters, denoted
by their different coloring scheme in Fig. 5a.
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Fig. 3 Expression of individual
receptor subtypes across all
neuromodulatory systems.
Charts were grouped by
neuromodulatory systems;
a adrenergic, b cholinergic,
c dopaminergic, and
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each system were arranged from
most (left) to least (right)
amount of expression along the
x-axis. Brain regions were
ordered from most (top) to least
(bottom) amount of total
expression energy for each
neuromodulator. The y-axis
shows the expression energy for
a given gene. Note that the
y-axis scale varies for
visualization purposes
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To examine the relationship between gene expression
and anatomical location, a separate hierarchical cluster
analysis was conducted using the centroid location for all
of the 13 brain regions (Fig. 5b). The procedure was
identical to the gene expression hierarchical cluster shown
in Fig. 5a, except that a vector of the (x, y, z) coordinates
from the reference atlas file (AtlasAnnotation200.sva) was
used for clustering instead of gene expression data. The
threshold for determining clusters was set to 0.02 to yield
four clusters, as in Fig. 5b.
The clusters shown in Fig. 5 suggest several relationships
between neuromodulatory receptor expression and anatomi-
cal location. The amygdala (AAA, MEA, CEA) and the SI
formed a tight cluster (Fig. 5a, blue) in gene expression, as
well as anatomically (Fig. 5b, cyan and purple). The SI and
basal forebrain are located near the amygdala (see Fig. 1) and
like the amygdala contain high overall neuromodulatory
receptor expression energy (see Figs. 2, 3). LC and NTS,
which contain noradrenergic neurons (McGaugh 2004;
Samuels and Szabadi 2008), formed a tight cluster both in
terms of gene expression and to a slightly lesser extent ana-
tomically [Fig. 5a (green), b (green and red)]. There was also
tight clustering among the raphe nuclei, the source of sero-
tonin in the CNS [Fig. 5a (red), b (red and green)].
There were a few receptor expression energy clusters
that did not match their anatomical cluster counterpart or
did not form a strong cluster based on expression. For
instance, the cholinergic sources SI and MA (Dani and
Bertrand 2007; Ishii and Kurachi 2006; Nicholas et al.
1996) did not cluster together based on expression energy,
though their distance apart from each other is still rela-
tively small (Fig. 5a, blue and green). However, they are
found in neighboring regions of the brain (see Fig. 1) and
thus clustered together based on their centroid location
(Fig. 5b, cyan). Perhaps the SI and MA not clustering
together may be due in part to their proportionally higher
expression energy across all four neuromodulatory systems
in the SI as compared to MA (see Figs. 2, 3). The dopa-
minergic region (VTA) and the CLI of the raphe nucleus
brain region did not fall within a cluster below the
threshold when analyzing gene expression (Fig. 5a).
However, in the anatomical cluster analysis, the VTA
clustered together with all the raphe regions, PPN, and
NTS (see Fig. 5, green and red), as they are located beside
each other (Fig. 1).
GABA and glutamate receptor distribution across SI
and LC
One of our main findings was that the SI of the basal
forebrain had high receptor expression energy for all four
neuromodulatory systems (Fig. 2). In contrast, the LC had
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Fig. 4 Distribution of gene
expression within the different
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represents the distribution of
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the lowest overall expression energy across the receptors
examined (Fig. 2).
To see if high expression energy in SI and low expres-
sion energy in LC existed for receptors other than neuro-
modulators, we measured the expression energy of GABA
and glutamate receptors in the SI and LC (see ‘‘GABA and
glutamate genes’’). We performed the same analysis as
before for acquiring expression energy and generating the
total expression of neuromodulatory systems found in the
SI and LC (see ‘‘Total expression and individual receptor
subtypes’’) with these GABA and glutamate receptors.
We found that, similar to the profile of neuromodulatory
receptors, the SI had very high expression energy of GABA
and glutamate receptors, while the LC was low. Figure 6
shows the total expression energy for GABA and glutamate
across the SI (top) and LC (bottom). For ease of visuali-
zation, in Fig. 6 we also included the total expression
energy of adrenergic, cholinergic, dopaminergic, and
serotonergic receptors from Fig. 2. The values in each bar
in Fig. 6 represent the accumulated amount of expression
energy when combining all subtypes per region. Note that
there is a much higher order of magnitude in expression
found in the SI compared to LC (Fig. 6).
Interestingly, we noticed a proportional relationship
between the receptor expression found in the SI and LC.
Though receptor expression in SI was much higher than in
LC, the relative distribution of expression between GABA,
glutamate, adrenergic, cholinergic, dopaminergic, and
serotonergic receptors had very similar profiles to the LC,
with glutamate receptors displaying the highest amount
of expression, followed by GABA, acetylcholine, and
serotonin (Fig. 6). This implies that the LC region has
proportionally lower receptor expression energy when
compared to SI, and other brain regions in this study. Since
the receptor expression energy was normalized over region
size (see ‘‘Methods’’), this lower overall receptor expres-
sion energy level reflects a unique property of the LC
region.
Contrast between ABA data and prior in situ
hybridization mRNA rat experiments
Although not exhaustive, neuroinformatics web resources
such as the Gene Expression Nervous System Atlas
(GENSAT) and the Neuroscience Information Framework
(NIF) provide an accessible way to obtain gene expression
data from various experiments (Heintz 2004; Gardner et al.
2008; Mu¨ller et al. 2008). We compared and contrasted
data reported from the ABA to results from studies
retrieved from these resources.
Table 2 shows the relative expression level in the brain
regions of interest per receptor subtype. This was accom-
plished by first querying NIF using all genes listed in
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Fig. 5 Hierarchical cluster of gene expression and location of brain
region. a The dendrogram was derived from the expression of
selected genes. b The dendrogram was derived from the x, y, z coor-
dinates of brain area centroid given in the reference atlas. The
dendrograms were generated using a Euclidean distance metric. The
cutoff for generating the different clusters was set to 0.19 for (a) and
0.02 for (b), which broke the hierarchical cluster into four separate
constitutes, denoted by their different coloring scheme
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Fig. 6 Total expression energy for GABA, glutamate, and neuro-
modulatory receptors across the substantia innominata (top) and locus
coeruleus (bottom). Expression energy from neuromodulatory recep-
tors is the same as in Fig. 2
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Table 2 Comparison between expression levels in the brain regions of interest per subtype found in rat literature and ABA
Brain Category 
Amygdala Dopaminergic Serotonergic Cholinergic Adrenergic 
G
en
e 
Su
bt
yp
e 
Adra1a (4, 8) 
Adra1d (4, 8) 
Adra2a (8, 12, 16) 
Adra2c (8, 12, 16) 
Adrb1 (11, 12) 
Adrb2 (11, 12) 
Chrm1 (3, 10) 
Chrm2 (3, 10) 
Chrm3 (3) 
Chrm4 (3, 15) 
Chrm5 (19) 
Chrna1 
Chrna2 (21) 
Chrna3 (21) 
Chrna4 (21) 
Chrna5 (22) 
Chrna6 (13) 
Chrna7 
Chrna9 
Chrnb1 
Chrnb2 (21) 
Chrnb3 
Drd1a (6) 
Drd2 (9) 
Drd3 (1, 5) 
Htr1a (14) 
Htr1b (2) 
Htr1d (2) 
Htr1f (2) 
Htr2b 
Htr2c (17) 
Htr3a (18) 
Htr3b (18) 
Htr4 (20) 
Htr5a (7) 
Htr5b (7) 
Htr6 (7) 
Htr7 (7) 
AAA, MEA, CEA RR, SNc, VTA DR, RPO, CLI, CS SI, MA LC 
Legend 
  No Expression Found (In Literature)   Higher Expression in ABA 
No Expression Found (In Both) Lower Expression in ABA 
  No Experiment Found (In Literature)   In Agreement 
No Experiment Found (In Literature) & No Expression Found (ABA) 
Data from previous studies taken from: (1) Bouthenet et al. (1991), (2) Bruinvels et al. (1994), (3) Buckley et al. (1988), (4) Day et al. (1997), (5)
Diaz et al. (1995), (6) Fremeau et al. (1991), (7) Kinsey et al. (2001), (8) McCune et al. (1993), (9) Mengod et al. (1989), (10) Narang (1995), (11)
Nicholas et al. (1993), (12) Nicholas et al. (1996), (13) Novere et al. (1996), (14) Pompeiano et al. (1992), (15) Pompeiano et al. (1994), (16)
Scheinin et al. (1994), (17) Sugaya et al. (1997), (18) Tecott et al. (1993), (19) Vilaro´ et al. (1990), (20) Vilaro´ et al. (2005), (21) Wada et al.
(1989), (22) Wada et al. (1990)
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Table 1. NIF returned results from GENSAT that con-
tained gene expression information from the mouse brain
based on bacterial artificial chromosomes (BACs) experi-
ments. However, because BAC experiments measure the
relative rates of transcription for each gene, it is thereby not
a direct measurement of mRNA accumulation. As such, in
addition to the BAC expression data, GENSAT provides
background literature, primarily from rat experiments, that
measure localized mRNA using ISH, which GENSAT uses
to correlate with their results. We utilized this feature to
collect prior literature on gene receptor expression locali-
zation and intensities.
Altogether, twenty-six papers were retrieved from
GENSAT to compare and contrast gene receptor expres-
sion with the ABA in Table 2. With the exception of two
receptors (Htr3a and Htr3b) coming from mouse literature,
and six not having any prior literature found in GENSAT
(Chrna1, Chrna7, Chrna9, Chrnb1, Chrnb3, Htr2b), all
remaining receptors from Table 1 were available in
GENSAT and feature rat brain in their experiment. As
such, it should be noted that Table 2 is an indirect com-
parison of species to species receptor expression. However,
all experiments retrieved from GENSAT document local-
ization of mRNA using ISH.
Once literature was acquired, classification of expres-
sion level in the prior studies was taken directly from the
wording in the corresponding reference. For example, some
studies stated relative values (high, moderate, low), while
others created tables using symbols (-, ?, ??, ???) to
denote the density of expression from in situ hybridization
analysis. Classification of expression level in the present
ABA study was based on the relative expression energy
within a brain category. Expression energy less than the
33rd percentile was classified as low expression, moderate
expression was between the 33rd and 66th percentiles, and
above the 66th percentile was considered highly expressed.
The 13 brain regions were condensed into 5 categories:
Amygdala (AAA, MEA, CEA), Dopaminergic (VTA),
Serotonergic (DR, RPO, CLI, CS), Cholinergic (SI, MA,
PPN), and Adrenergic (LC, NTS) neuron regions. To
determine the energy of expression, the average expression
across these categorized brain regions was computed, and
then percentiles were calculated across each gene in each
category. If the expression of a gene (row) in a brain cat-
egory (column) from the ABA coincided with previous
work, then we considered the comparison to be in agree-
ment, and the green entries in Table 2 denoted this. If the
expression in the ABA was classified higher than in prior
experiments, the table entry was colored red. Blue denoted
lower expression in the ABA than in prior studies. Gray
entries in the table represent expression data not found in
previous studies, while yellow entries represent experi-
ments not conducted in the literature. In the case where
there was no expression found, but experiments conducted,
in both the literature and ABA, entries were flagged in
orange. Black entries represent a unique case where, for a
given gene, no data was found in the ABA, but no exper-
iment conducted in the literature.
In general, the comprehensiveness of the ABA revealed
information that was previously unreported (Table 2, gray
and yellow entries), and reported higher receptor expres-
sion in the amygdala and basal forebrain across all neu-
romodulatory systems than in previously reported studies
(Table 2, red entries).
Network visualization and connectivity
In order to better analyze complex systems of interaction,
Pajek, a software package designed for examining large
networks (Batagelj and Mrvar 1998), was used to visualize
potential connectivity relationships between brain regions
based on expression data from the ABA. We make the
assumption that given a neuromodulatory source, such as
VTA, we can infer the strength of a projection to a target
area from that source based on the receptor expression
energy (e.g., by looking at the overall dopaminergic
expression energy in a target region).
Figure 7 shows the overall relationship among the neu-
romodulatory systems along with its interactions with the
amygdala. Nodes corresponded to either a class of neuro-
transmitter source (e.g., ACh from SI, MA, and PPN) or the
different regions of the amygdala, which were recipients of
neuromodulation. Directional arcs represented inferred
projections from a neuromodulatory system to a target brain
area. The thickness of each arc was proportional to the
amount of receptor expression energy found in the target
region. The diameter of each node represented the total
amount of receptor expression energy in that brain region.
For example, the cholinergic receptor expression energy in
MEA was much higher than serotonergic, as can be seen in
Fig. 7 by the thickness of the arc (compare the arc
extending from green node to MEA with the arc extending
from the red node to MEA). All networks from Pajek were
rendered using the circular layout; all other parameters were
set to default. For ease of visualization, the amounts of
receptor expression energy were scaled down, dividing the
amount of receptor energy expression by 100.
Expression energy emanating from the cholinergic sys-
tem is overwhelmingly the highest, followed by seroto-
nergic, dopaminergic, and adrenergic (Fig. 7). All
neuromodulatory systems project heavily to the cholinergic
system as compared to other brain regions (Fig. 7 green
node). The rest of the projections remained relatively low,
though there may be an indication that serotonin projects
more heavily to AAA compared to other amygdala areas
(Fig. 7).
1524 Brain Struct Funct (2013) 218:1513–1530
123
In addition to looking at the overall neuromodulatory
connectivity network, we examined the influence of
receptor subtypes on the different brain regions. Families
of receptors were categorized in the following way:
a (Adra1a, Adra1b, Adra2a, Adra2c) versus b (Adrb1,
Adrb2) adrenergic receptors; muscarinic (Chrm1, Chrm2,
Chrm3, Chrm4, Chrm5) versus nicotinic (Chrna1, Chrna2,
Chrna3, Chrna4, Chrna5, Chrna6, Chrna7, Chrna9, Chrnb1,
Chrnb2, Chrnb3) cholinergic receptors; D1 (Drd1a) versus
D2 (Drd2, Drd3) dopaminergic receptors; and serotonin
receptors that produce an inhibitory response (Htr1a,
Htr1b, Htr1d, Htr1f, Htr5a, Htr5b) versus serotonin
receptors that produce an excitatory response (Htr2b,
Htr2c, Htr3a, Htr3b, Htr4, Htr6, Htr7).
In general, different families of receptors had noticeable
differences in how they are distributed across different
brain regions (see Figs. 8, 9, 10, 11). For comparison
purposes, the layout, arc thickness, and node diameter
proportions were scaled down, dividing the amount of
receptor energy expression by 1,000 for Figs. 8, 9, 10, 11.
Expression energy from a-adrenergic receptors (Fig. 8,
top) was more prevalent in cholinergic regions, as well as
in the anterior amygdalar area (AAA), and within itself
compared to b-adrenergic receptors (Fig. 8, bottom), which
had a stronger influence on dopaminergic areas. Both the
D1 and D2 dopamine families had a strong influence on the
regions associated with acetylcholine and the CEA
(Fig. 9); however, the D2 family of receptors expressed
more within dopaminergic sources compared to D1 (Fig. 9,
bottom). Muscarinic acetylcholine expression (Fig. 10,
top) was higher than nicotinic expression in the amygdala
(MEA, CEA), while nicotinic receptors (Fig. 10, bottom)
were more strongly expressed in the dopaminergic areas.
VTA
LC, NTS
SI, MA, 
PPN
DR, CS, 
CLI, RPO
AAA
CEA
MEA
Fig. 7 Network model showing overall expression of neuromodula-
tory receptors and their implied neuromodulatory projections to target
areas. Vertices represent brain regions that are either standalone
(AAA, CEA, MEA) or are combined regions (sources of neuromod-
ulators). Directed arcs represent projections going to and coming
from a source. The pointed-arrow indicates the target location and the
non-arrow end of the arc indicates the origin. The thickness of each
arc, as well as the size of vertices, is proportional to the amount of
expression found in the target location. Colors were used for
visualization purposes, similar to Figs. 2 and 3
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Fig. 8 Network model comparison between the expression energy of
a and b adrenergic receptors
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Fig. 9 Network model comparison between the expression energy of
muscarinic and nicotinic cholinergic receptors
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As for the serotonergic receptors, the amount of expression
was roughly the same for the inhibitory and excitatory
HTR families (Fig. 11).
Discussion
Using the ABA, we conducted an exploratory survey of
receptor expression energy in the classical neuromodulatory
systems (i.e., cholinergic, dopaminergic, noradrenergic,
serotonergic) within anatomical origins of these neuromod-
ulatory systems and in the amygdala. These systems are
somewhat unique in that the sources of the neurotransmitters
are localized to small subcortical nuclei. The present study
examined neuromodulatory receptor expression energy in the
amygdala, which is thought to be a major target of neuro-
modulation, and within the sources of neuromodulation
themselves (McGaugh 2004, 2006; Gallagher and Chiba
1996). Based on these assumptions, we were able to infer the
targets of these neuromodulatory systems using receptor gene
expression data from the ABA.
Although the present study was an exploratory survey of
specific neuromodulatory receptor expression, several findings
emerged from the study that could have functional implica-
tions: (1) Cholinergic receptors are overwhelmingly higher
expression in the neuromodulatory nuclei than in the other
classic neuromodulatory systems. Figures 2 and 7 show that
the expression of cholinergic receptors is an order of magni-
tude higher than serotonin and norepinephrine, and much
higher than dopamine. (2) The level of adrenergic expression
was surprisingly small in all the brain areas tested. Moreover,
the amount of neuromodulatory expression within the locus
coeruleus was very low compared to other regions. Interest-
ingly, the NTS, which is another source of noradrenergic
neurons, displayed comparatively moderate expression energy
of all neuromodulatory receptors. (3) The SI and VTA appear
to be hubs, or ‘rich clubs’ of neuromodulation (van den Heuvel
and Sporns 2011). In particular, the SI had the highest
expression of all four neuromodulatory receptors compared to
the other brain regions examined. (4) The amygdala is another
hub of neuromodulation, with high receptor expression energy
from all 4 neuromodulatory classes. Interestingly, SI is an
anatomical neighbor of the amygdala making this anatomical
region a neuromodulatory hub. (5) Lastly, the comprehensive
ABA allowed the present survey to fill in many gaps in our
knowledge of receptor expression using ISH. To the best of our
knowledge, many of the results in the present study have not
been reported previously in the rodent brain, as can be seen by
the gray cells of Table 2.
VTA
LC, NTS
SI, MA, PPN
DR, CS, 
CLI, RPO
AAA
CEA
MEA
VTA
LC, NTS
SI, MA, PPN
DR, CS, 
CLI, RPO
AAA
CEA
MEA
ACh (Muscarinic) Sources
ACh (Nicotinic) Sources
Fig. 10 Network model comparison between the expression energy
of D1 and D2 family dopamine receptors
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Fig. 11 Network model comparison between the expression energy
serotonin receptors that produce an inhibitory response (Htr1 and
HTR5) and serotonin receptors that produce an excitatory response
(Htr2, Htr3, Htr4, Htr6 and Htr7)
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It should be noted that our comparisons and interpretations
may be influenced by a number of factors beyond the scope of
this survey, including (1) differences in detection sensitivity
between different mRNA species, which cannot be ruled out
despite the ABA performing validation experiments, ensur-
ing consistent data quality and internal reproducibility (see
‘‘Neuromodulatory Genes’’), (2) not all receptor subtypes
could be analyzed for some systems. For example, D4 and D5
were not present in the ABA, (3) mRNA may be transcribed,
but not translated, into functional receptor proteins, and
(4) the expression energy for a particular receptor may not
necessarily be located at the synapse, or could be located pre-
synaptically or post-synaptically (Feuerstein 2008; Gilsbach
and Hein 2008; Wonnacott 1997). These cautionary remarks
do not necessarily invalidate the present results, but they
serve as a reminder that these factors should be considered
and possibly investigated in future experiments using other
methods, such as Western blots, to verify the present findings
(Tebbenkamp and Borchelt 2010).
The completeness of the ABA allowed us to observe
interesting patterns of neurotransmitter receptor expression
energy, which may supplement current anatomical
knowledge on neuromodulatory systems. Many of these
expression patterns had not been previously reported
(Table 2, gray and yellow entries). The amygdala (AAA,
CEA, MEA), SI, and VTA showed the highest receptor
expression energy of the regions examined (Fig. 2). The
pattern of expression, for the most part, was similar within
neuromodulator classes and among anatomical regions
(compare Fig. 5a to b). Within an anatomical region, such
as the amygdala, distinct patterns of receptor expression
were observed across subregions (Fig. 4).
Bearing in mind that literature retrieved from GENSAT
to compare and contrast receptor expression energies with
the ABA in Table 2 originates primarily from rat studies
(with the exception of Htr3a and Htr3b); our ABA survey
suggests that the amygdala tended to show higher expression
of neuromodulatory receptors than previously reported
(McGaugh 2004; Han et al. 1999; Meneses and Perez-Garcia
2007; Haber et al. 1995) (Table 2, Amygdala column).
Among the prominent gene expression in the amygdala
(Fig. 4), Chrm1, Chrm2, and the dopaminergic receptors
were in agreement with literature findings (Narang 1995;
Buckley et al. 1988) (Table 2). The rest, which includes
Adra1d, Adrb2, Htr1f, Htr2c, and Htr3a has higher expres-
sion energy in the ABA than what was previously reported
(Nicholas et al. 1996; Day et al. 1997; Goldman et al. 1986;
Bruinvels et al. 1994); (Pompeiano et al. 1994). Though
there were a few genes that did not have abundant expression
yet were in agreement with literature data (Adra2a, and
Chrna3), the remaining genes were either considered to have
more expression than has been found, or no data was
available for comparison (Table 2, Amygdala column).
Our findings for neuromodulatory receptor expression
energy in the midbrain area, where dopaminergic neurons
are found, in many places agreed and disagreed with pre-
vious work (Table 2, Dopaminergic column). In particular,
we found that all of the a-adrenoreceptors, along with
Chrna6, Chrnb3, Drd2, Htr4, and Htr6 were all in agree-
ment with studies that have also shown expression from
these receptors in the midbrain region (Day et al. 1997;
Novere et al. 1996; Deneris et al. 1989; Vilaro´ et al. 2005;
Kinsey et al. 2001).
The raphe nuclei, which are a source of serotonergic
neurons, had fairly low expression energy overall (Fig. 2),
and this expression was in agreement with several other
studies (Table 2, Serotonergic column). More specifically,
Adra2a, Adra2c, Adrb2, Chrna3, Htr1a, Htr1b, and Htr1d,
had low-to-moderate expression energy in the present ABA
and other studies (McCune et al. 1993; Scheinin et al.
1994; Nicholas et al. 1996). However, several receptor
genes showed higher expression in the ABA than was
previously reported (Adra1d, Chrna4, Chrnb2, Htr1f), as
well as some receptor genes that displayed lower expres-
sion in the ABA than stated in prior literature (Chrm4,
Chrna5, Htr5a, Htr5b). Still, we were not able to find data
on many genes, with one gene in particular (Chrnb1) not
found in both the literature and ABA data set (Table 2,
Serotonergic column, gray, yellow and black entries).
Conversely, our findings in the basal forebrain (espe-
cially the SI), a source of cholinergic neurons, which
showed the highest amount of expression out of all the brain
regions in this study (Fig. 2), had very little agreement with
literature data (Table 2, Cholinergic column). It has been
reported that there are efferent projections of the adrenergic
and serotonergic systems into the basal forebrain (Holm-
strand and Sesack 2011; Samuels and Szabadi 2008;
Hornung 2003). However, the present study suggests a
significantly larger neuromodulatory innervation of the
basal forebrain, compared to other neuromodulatory
regions, than previously reported. Adrenergic (Adra1a,
Adra1d, Adrb1, Adrb2) and cholinergic (Chrm4, Chrna2,
Chrna3, Chrna4, Chrnb2) receptors were classified as hav-
ing higher expression in the ABA than in previous studies.
However, no information in literature data was found for the
remaining receptors (Table 2, Cholinergic column, gray
entries). That, along with the substantially high receptor
expression energy found in the SI in this survey, suggests
that future studies should focus on this region.
The locus coeruleus and the NTS, which are major
sources of noradrenergic neurons, had several genes that
were classified as having lower expression energy in the
ABA than other studies (Fig. 2; Table 2, Adrenergic col-
umn). Adra2a, Chrna2, Chrna3, Chrna6, and Htr1b were all
reported to have moderate-to-high expression in the locus
coeruleus, yet the data in the ABA suggest lower
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expression (McCune et al. 1993; Scheinin et al. 1994;
Nicholas et al. 1996) (Table 2, Adrenergic column). Fur-
thermore, Htr7 was the only gene that had no data in both
the ABA and literature (Table 2, Adrenergic column,
orange entry). In terms of agreement, only the Adra2c,
Adrb2, Htr1d, and Htr2c receptors, which had low-
to-moderate energy of expression, match former findings
(McCune et al. 1993; Scheinin et al. 1994; Nicholas et al.
1996; Goldman et al. 1986; Wada et al. 1989; del Toro
et al. 1994; Bruinvels et al. 1994; Mengod et al. 2006;
Pompeiano et al. 1994). All other genes were not found in
literature (Table 2, Adrenergic column, gray entries).
The completeness of the Allen Brain Atlas for the mouse
brain is a rich source for exploratory studies and made the
present neuroinformatics study possible (Lein et al. 2007;
Jones et al. 2009). Our study, which took advantage of the
somewhat unique structure of the neuromodulatory systems,
was able to create a connectivity map from the sources of
neuromodulation to their receptor targets in the amygdala and
the neuromodulatory nuclei (see Figs. 7, 8, 9, 10, 11). The
study revealed connectivity relations and receptor localiza-
tion that had not been reported previously. The pattern of
expression varied across regions, not just in the level of
expression, but also by receptor subtypes. These variations
may have functional and anatomical implications.
Our survey of the ABA showed interesting and novel
relationships between the neuromodulatory systems and the
amygdala. The comprehensive mouse atlas provided by the
ABA allowed us to form a more complete picture of these
interactions than seen previously. The methodology pre-
sented here may be applied to other neural systems with
similar characteristics, and to other animal models as their
brain atlases become available.
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